Trial of Neoadjuvant Short Course IMRT Followed by Surgery and IORT for Resectable Pancreatic Cancer (NEOPANC)

This study is not yet open for participant recruitment.

Verified June 2011 by University Hospital Heidelberg

Sponsor:

Collaborator:

German Cancer Research Center

Information provided by:

University Hospital Heidelberg

ClinicalTrials.gov Identifier:

NCT01372735

First received: June 9, 2011

Last updated: June 10, 2011

Last verified: June 2011

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is not yet open for participant recruitment.
Estimated Study Completion Date:	August 2017
Estimated Primary Completion Date:	August 2013 (Final data collection date for primary outcome measure)

No publications provided by University Hospital Heidelberg

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Roeder F, Timke C, Saleh-Ebrahimi L, Schneider L, Hackert T, Hartwig W, Kopp-Schneider A, Hensley FW, Buechler MW, Debus J, Huber PE, Werner J. Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 Gy) and intraoperative radiation therapy (15 Gy) in patients with primarily resectable pancreatic cancer - NEOPANC. BMC Cancer. 2012 Mar 23;12:112.

To Top